{"id":3006,"date":"2013-10-24T14:15:02","date_gmt":"2013-10-24T14:15:02","guid":{"rendered":"\/?p=3006"},"modified":"2013-10-24T14:15:38","modified_gmt":"2013-10-24T14:15:38","slug":"under-1-again-titan-pharmaceuticals-inc-otcbbttnp-keeps-silence-awaits-november-verdicts","status":"publish","type":"post","link":"\/articles\/under-1-again-titan-pharmaceuticals-inc-otcbbttnp-keeps-silence-awaits-november-verdicts\/","title":{"rendered":"Under $1 again, Titan Pharmaceuticals, Inc. (OTCBB:TTNP) Keeps Silence, Awaits November Verdicts"},"content":{"rendered":"

Titan Pharmaceuticals, Inc. (OTCBB:TTNP<\/a>) is flirting again with the $1 levels, standing at 92 cents after adding more than 9% on dollar volumes above 400K. While TTNP<\/a> remains relatively active, we are not seeing the rally and recovery that was expected sooner rather than later. \"TTNP1024.png\" <\/p>\n

Investors’ forums are still full of optimism, stating that TTNP<\/a> is still a steal at those prices. And the time between now and the FDA review meeting on November 19th is getting narrower, which may add upward pressure to the price.\"LJPV1024.png\"\"BZNE1024.png\"<\/p>\n

The company has been silent with press releases for nearly a month, gathering up presentation data and mostly betting on a positive verdict. Some negative news have slipped through the silence- that TTNP<\/a> has not made new trials or improvements since the voting this spring. Also, the company was hoping for a B-meeting, and now will receive the lower attention of a C-type meeting.<\/p>\n

TTNP<\/a> now faces the end-of-the week drama, where selling may begin anew. The downward pressure is significant, with five days of selling before the day of recovery.<\/p>\n

In the past few days, the fate of TTNP<\/a> was shared by several pharmaceutical tickers, which traditionally quickly lose their glitter. La Jolla Pharmaceutical, Co. (OTCBB:LJPC<\/a>) is falling for a second day in a row, wiping out around a fifth of its value, moving away from the 24-cent peak.<\/p>\n

Biozone Pharmaceuticals, Inc. (OTCBB:BZNE<\/a>) is another concern of the last day where a takeoff was expected, and instead a tangled mess of erratic movements happened, with selling still prevailing. BZNE<\/a> stands at 68 cents, with a negligible fall compared to the previous day, as nearly 10 million shares were shed in decreasing volumes in the past four days.<\/p>\n

If you are still waiting for clarity with TTNP<\/a>, it may never arrive. It is best not to rely too much on another one of those great positive developments, and instead to decide on an affordable investment and a desirable outcome. While TTNP<\/a> has a solid background compared to other pharmaceutical companies, the latest Probruphine therapy is threatening to take enough troubles to the surface.<\/p>\n

The pharmaceutical sector is remaining extremely active right now, with newcomers and old names returning. Yet in the past few days, a lot of positive trends broke suddenly. If you cannot afford losses of a significant part of your investment, avoid investing in those peaking tickers, since the correction comes without warning.<\/p>\n","protected":false},"excerpt":{"rendered":"

Titan Pharmaceuticals, Inc. (OTCBB:TTNP) is flirting again with the $1 levels, standing at 92 cents after adding more than 9% on dollar volumes above 400K. While TTNP remains relatively active, we are not seeing...<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1022,1028,11],"class_list":["post-3006","post","type-post","status-publish","format-standard","hentry","category-news","tag-bzne","tag-ljpc","tag-ttnp"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/3006","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=3006"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/3006\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=3006"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=3006"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=3006"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}